Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Combination therapy for the treatment of acute leukemia and myelodysplastic syndrome

Combination therapy for the treatment of acute leukemia and myelodysplastic syndrome

US Patent 7727968 · Granted Jun 1, 2010

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Methods for treatment of patients with myelodysplastic syndromes2024
Dosage regimes for the administration of an anti-CD19 ADC2024
Anti-CD45-based conditioning methods and uses thereof in conjunction with gene-e2024
Combination therapy with an anti-CD25 antibody-drug conjugate2023
Methods for treating vascular eye disorders with ActRII antagonists2022
Dosage regimes for the administration of an anti-CD25 ADC2022
Dosage regimes for the administration of an anti-CD19 ADC2022
Methods for treating vascular eye disorders with actrii antagonists2020
Antagonists of activin-ActRIIa and uses for increasing red blood cell levels2018
Follistatin fusion proteins and uses thereof2018
Treatment of chronic neutrophilic leukemia (CNL) and atypical chronic myeloid le2016
Activin-actriia antagonists for treating a follicle-stimulating horomone-secreti2016